A proposed protocol for UVBnb phototherapy in a patient with severe AD and mild PSO treated with dupilumab

Ital J Dermatol Venerol. 2024 Jun;159(3):358-360. doi: 10.23736/S2784-8671.23.07687-9. Epub 2024 Jan 10.

Authors

Vittoria Cioppa¹, Laura Lazzeri², Francesca Falcinelli², Pietro Rubegni², Filomena Russo²

Affiliations

¹ Unit of Dermatology, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy - v.cioppa@student.unisi.it.
² Unit of Dermatology, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.

PMID: 38197614
DOI: 10.23736/S2784-8671.23.07687-9

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / therapeutic use
Dermatitis, Atopic* / drug therapy
Female
Humans
Male
Middle Aged
Severity of Illness Index
Ultraviolet Therapy*

Substances

Antibodies, Monoclonal, Humanized
dupilumab